🇪🇺EU · EMAWithdrawnATC: J07BC

Hepacare(hepatitis B surface antigens recombinant (S, pre-S1, pre-S2) adsorbed on aluminium hydroxide [produced on genetically engineered murine (C127I) cells])

Hepatitis B;Immunization

Marketing Authorisation Holder: Evans Vaccines Ltd.

EMA Authorisation: 04/08/2000

INN: hepatitis B surface antigens recombinant (S, pre-S1, pre-S2) adsorbed on aluminium hydroxide [produced on genetically engineered murine (C127I) cells]

Indication

This vaccine is indicated for active immunisation against hepatitis B virus infection in non-immune adults (>=18 years). The specific at risk categories to be immunised are to be determined on the basis of official recommendations.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Hepacare — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Ask about Hepacare Create Free Account

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.